APGE Latest Headlines

Analysts’ Top Healthcare Picks: Aveanna Healthcare Holdings (AVAH), Apogee Therapeutics (APGE)

at www.tipranks.com (Fri, 12-Jun 5:20 AM)

Salveen Richter Reiterates Hold on Apogee; Maintains $89 Price Target Amid Long-Term Promise and Pipeline Uncertainty

at www.tipranks.com (Thu, 11-Jun 8:55 AM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (APGE), Inventiva (IVA) and Roche Holding AG (OtherRHHVF)

at www.tipranks.com (Mon, 8-Jun 7:40 AM)

Apogee Secures $1.3 Billion Non-Dilutive Funding, Paving the Way for Zumilokibart’s Phase 3 and Commercialization

Market Chameleon (Wed, 27-May 7:05 AM)

Apogee Therapeutics Raises $350 Million in Public Offering, Targeting Innovation in Inflammatory Markets

Market Chameleon (Wed, 25-Mar 11:12 AM)

Apogee Therapeutics Secures $350 Million in Public Offering—Strengthens Pipeline for Inflammatory Diseases

Market Chameleon (Wed, 25-Mar 8:21 AM)

Apogee's Zumilokibart Delivers Sustained Results in Phase 2: Up to 85% Efficacy Maintained with Long-Interval Dosing for Atopic Dermatitis

Market Chameleon (Mon, 23-Mar 10:29 AM)

Apogee’s Zumilokibart Maintains and Deepens Responses in Atopic Dermatitis Over 52 Weeks — Could Twice-Yearly Dosing Be a New Standard?

Market Chameleon (Mon, 23-Mar 7:05 AM)